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Letters to the Editor
COMMENTS ON "RESPONSE OF HUMAN LYMPHOCYTES TO PHA AND
TUMOUR-ASSOCIATED ANTIGENS AS DETECTED BY FLUORESCENCE
POLARIZATION". Br. J. Cancer, 41, 73 (1980)
SIR,-I have examined the results of
Balding et al. (Br. J. Cancer, (1980) 41, 73)
and find that their intracellular fluorescein
polarization measurements on human lym-
cytes are in disagreement with those from
several other laboratories, and fraught with
stray-light artifacts forthefollowing reasons:
An asymptotic decrease of P values with
increasing time of incubation in the FDA
substrate (Figure, square symbols) indicates
a stray-light artifact. This artifact can be
eliminated by improving the resolution ofthe
monochromators by mounting the primary
blue FITC filter (Barr & Stroud Ltd., U.K.)
between the excitation monochromator and
polarizer as well as the GG 495 cut-off
filter (Barr & Stroud) on the emission side
(Cercek & Cercek, 1979). Elimination of the
stray-light artifact produces a much reduced
linear decrease in P values with time of
incubation (Figure, circle, cross and tri-
angle symbols) of only 0-36 and 0.88%/min
in 0-65 and 2-4uMm FDA substrate, respec-
tively. In agreement with these artifact-
free results, a linear, not asymptotic, decrease
of P values by only 0.7%/min over the first
30 min of FDA hydrolysis was observed
in EL4 cells by Epstein et at. (1977) using a
calculating flow polarization-meter. As would
be expected in the presence of stray-light
artifacts, the results of Balding et al. in
Fig. 2 exhibit a sharp decrease in P within
the first 7 min of hydrolysis followed by
a linear, much slower decrease in P of only
0 8%/min. This latter value agrees with our
results in 2-6ytM FDA substrate (0.88%/
min) and also with that obtained for EL4
cells (0-7%/min) by Epstein et al. (1977)
Therefore, to account for a 10% decrease in
P at least a 10 fold increase in intracellular
concentration of fluorescein over that advo-
cated by Balding et at. would be required
to support their suggestions. For example,
the flow polarization meter results of Udkoff
& Norman (1979) show that in human
lymphocytes an 800% increase in intra-
cellular fluorescein concentration is required
for a 10% reduction in P. Our own results
14
in Fig. 1 indicate that a 10% reduction in
P requires 6000%, and 400%, increase in
intracellular concentrations of fluorescein
in 0-65/tM, and 2-6pM, FDA substrate
respectively.
Evidence for stray-light artifacts in the
polarization measurements of Balding et al.
can also be inferred fromtheir statement that
more consistent results were obtained when
the pipetting errors were minimized. Since
the polarization values are a ratio of fluores-
cence intensities, changes in cell numbers
should only affect polarization values if
stray-light artifacts were measured (Cercek
et at., 1978). In addition, our own measure-
ments on the identical fluorescence spectro-
photometer to that used by Balding et al. in
Prof. Bleehen's laboratory at Cambridge
showed that both FITC and GG495 optical
filters had to be installed to eliminate stray-
light artifacts. Furthermore, as Dr J. A. V.
Pritchard (personal communication) writes
"the results presented by Balding et al. in
his Fig. 10 were obtained in the Cardiff
MPF-4 fluorescence spectrophotometer from
a single blood sample, without stray-light
filters, before the correct protocol had been
established for successful and consistent
operation of the SCM-test in Cardiff and were
published without the prior knowledge of
the Cardiff group". Stray-light artifacts are
also evident from the asymptotic relation-
ship between P and time of FDA hydrolysis.
Our previous report that the degree of
fluorescence polarization was the same when
the measurements were made 3 and 15 min
after the cells were suspended in 0-7,M
FDA (Cercek et at., 1978) does not contradict
the present report. For a 0.36% decrease in
polarization per min, the change in
polarization over 15 min is 4-3%, and could
not have been distinguished from the
experimental error, even less so in the SCM
test when measurements are made at time
constant to within+ 1 min. The decrease
became apparent only when the incubation
times were extended to beyond 15 min.
It follows from the above argument that,208 ,LETTERS TO THE EDITOR
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FIGURE.--Effect of time of incubation in the
FDA substrate solution on the intracellular
fluorescein fluorescence polarization of
human lymphocytes. In 0'65/tM FDA
prepared from a glacial-acetic acid FDA
stock solution: emission GG495 optical
filter only ([); both emission GG495 and
excitation FITC optical filters (0). In
2.6uM FDA prepared from an acetone
FDA stock solution: emission GG495
optical filter only (A); both emission
GG495 and excitation FITC optical
filters (x). In all experiments cells were
incubated in bulk under constant stirring
in FDA solutions kept at 270C and 3ml
samples were withdrawn at various inter-
vals. The correlation coefficient, a measure
of the tightness of the linear relationship
between P values and time of incubation,
is 0-98.
because of stray-light artifacts, the conclu-
sions of Balding et al. on the effects of time
of FDA hydrolysis and of changes in the
intracellular fluorescein concentration on the
results ofthe 'SCM test" areinconsequential.
B. CERCEK
Paterson Laboratories,
Christie Hospital and
Holt Radium Institute,
Manchester
SIR,-We are perplexed that Balding et al.,
in their recent paper (Br. J. Cancer, (1980)
41, 73) overlooked the fact that the success-
ful accomplishment of the SCM test depends
on the isolation of a specific subpopulation of
lymphocytes (Cercek & Cercek, 1977, 1978a,
b; Takaku et al., 1977; Hashimoto et al.,
1978; Kreutzmann et al., 1978; Pritchard and
Sutherland, 1978; Pritchard et al., 1978;
Orjasaeter et al., 1979). In contrast to 90%
pure density-specific lymphocytes (of which
more than 75% are T cells) used in the SCM
test, their cell preparations contained an
average of only 67% lymphocytes with an
undefined proportion of T cells. It is obvious
that the experimental conditions for the
isolation of SCM responders were not strictly
followed. For example, their "cell prepara-
tions b" were isolated at 13°C instead of at
16.7°C (calculated from their data on the
osmolality and density of the Ficoll-Triosil
solution) resulting in the isolation of SCM-
non-responding lymphocytes (Cercek & Cer-
cek, 1978b). Other critical deviations from the
SCM protocol include the use of HEPES
instead of phosphate buffer in their "cell
preparations a" as well as the use of acetone
in the preparation of the FDA substrates.
Both HEPES buffer (unpublished results)
and impurities in the acetone diminish or
abrogate SCM responses to PHA and cancer
antigens (Cercek & Cercek, 1976, 1977).
Furthermore, they claim that on PHA
stimulation of lymphocytes the rate of
fluorescein diacetate (FDA) hydrolysis incre-
ses and the leakage of fluorescein decreases.
In contrast, a detailed study on the effects
of PHA on the kinetics of FDA hydrolysis
in human lymphocytes (Mullen & Campbell,
1979) and the data of Cercek & Cercek
(1978a) show that the rate ofFDA hydrolysis
decreases on PHA stimulation by an average
of 40%. It has also been reported that
binding ofmitogens such as PHA and Con-A
to the plasma membrane of lymphocytes
increases its fluidity and permeability
(Greaves & Janossy, 1972; Collard et al.,
1977). To this we can add our own observa-
tions from hundreds of measurements on
SCM-responding lymphocytes from healthy
donors, cancer patients or donors with
other diseases, which show that after PHA
stimulation the permeation of fluorescein
always increases by 5-150% according to the
batch of PHA, over that of the controls.
Therefore, at a constant time of FDA